PALYNZIQ
3 569,64 R$
Max. consumer price (CMED)
Analogs of PALYNZIQ
Find cheaper analogs and generic equivalents for PALYNZIQ.
ਸਰਗਰਮ ਤੱਤ: pegvaliase
ਉਤਪਾਦ ਝਲਕ
About PALYNZIQ
PALYNZIQ is a medication containing the active ingredient pegvaliase, classified as Phenylalanine Metabolizing Enzyme. Pegvaliase, sold under the brand name Palynziq, is a medication used for the treatment of the genetic disease phenylketonuria (PKU). It is a phenylalanine (Phe)‑metabolizing enzyme.
Key Benefits & Uses
- Used for: 1 INDICATIONS AND USAGE PALYNZIQ is indicated to reduce blood phenylalanine concentrations in adult and pediatric patients 12 years of age and older.
- Use only as directed on the product label or by a healthcare professional.
- Follow the authorised product information for dosing and duration of use.
Active Ingredient & Action
pegvaliase, the active ingredient in PALYNZIQ, belongs to the Phenylalanine Metabolizing Enzyme class. 1 INDICATIONS AND USAGE PALYNZIQ is indicated to reduce blood phenylalanine concentrations in adult and pediatric patients 12 years of age and older with phenylketonuria (PKU) who have uncontrolled blood phenylalanine concentrations greater than 600 micromol/L on existing management. Inactive ingredients: not listed in source data.
Important Notes
Always read and follow the label instructions carefully before taking PALYNZIQ. If you have any underlying medical conditions, are taking other medicines, or are pregnant or breastfeeding, consult a doctor or pharmacist before use. Do not exceed the recommended dose on the package and do not use PALYNZIQ for extended periods without medical advice.
Visitor ratings
Help others by rating how useful this product page is.
No ratings yet — be the first.